JOURNAVX

Clinical trials for JOURNAVX explained in plain language.

Never miss a new study

Get alerted when new JOURNAVX trials appear

Sign up with your email to follow new studies for JOURNAVX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to cut opioid use after hip surgery

Symptom relief Recruiting now

This study is testing a new, FDA-approved non-opioid pain medication called Suzetrigine (Journavx™) for people having hip replacement surgery. The goal is to see if it can effectively manage post-surgery pain and reduce the need for traditional opioid painkillers, which can have …

Matched conditions: JOURNAVX

Phase: PHASE3 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief

Last updated Mar 13, 2026 15:06 UTC

JOURNAVX

Get alerted when new JOURNAVX trials appear

New drug aims to cut opioid use after hip surgery